2.01(b)
Agreement
Preamble
AMEX
2.03(i)
Antitrust Laws
7.05(b)
Assets
3.17
Audited Financial Statements
3.08(a)
Back Up Transaction
5.18
Beneficial Owner
11.02(a)
Business Day
11.02(a)
CERCLA
3.13
Certificate of Merger
1.02
Closing
1.02
Closing Date
1.02
Closing Members' Equity
2.03(a)
COBRA
3.11(d)
Code
2.04(g)
Common Control
3.06(c)
Company
Preamble
Company Basic Representations
10.01
Company Confidential Information
3.14(f)
89
Term
Section
Company Disclosure Schedule
Article III
Company Financial Statements
3.08(a)
Company Insiders
7.12
Company Intellectual Property
3.14(a)
Company Interest
Recitals
Company Interest Certificates
2.02(a)
Company Interest Exchange Ratio
2.01(a)
Company Material Adverse Effect
3.01
Company Permits
3.07(a)
Company Warrant
2.04(b)
Company's 2006 Annualized Adjusted EBITDA
11.02(a)
Competing Transaction
7.03(b)
Control
11.02(a)
Contributing Members
11.02(a)
Current Assets
2.02(a)(ii)
Current Liabilities
2.02(a)(ii)
DGCL
Recitals
Dispute Notice
2.03(b)
Earnout Award Calculation
2.06(f)
Earnout Award Shares
2.06(d)
Earnout Dispute Notice
2.06(f)
Earnout Notice
2.06(e)
Earnout Per Share Market Value
2.06(b)
EBITDA
11.02(a)
Effective Time
1.02
Employee Obligation
3.14(i)
Employment Agreement(s)
7.04(b)
Environmental Laws
3.13
Environmental Permits
3.13
ERISA
3.11(a)
ERISA Affiliate
3.11(e)
Escrow Account
2.04(b)
Escrow Agent
2.04(b)
Escrow Agreement
2.04(b)
Escrow Amount
2.01(b)
Escrow Fund
2.04(b)
Escrow Per Share Market Value
2.03(i)
Escrow Securities
2.04(a)
Escrow Shares
2.01(b)
Escrow Warrants
2.04(a)
Estimated Closing Working Capital
2.02(b)
Estimated Members' Equity
2.02(b)
Estimated Net Enterprise Value
2.01(b)
Estimated Third Party Indebtedness
2.01(b)
Exchange Act
5.04(a)
Exchange Agent
2.02(a)
90
Term
Section
Exchange Value
2.08(a)
Execution Date
Preamble
Final Conversion Schedule
7.15
FIRPTA
8.02(q)
Form S-4 Alternative
7.01(c)
Founders
8.01(a)
Fully Diluted Company Interest Amount
2.01(a)
Fully Diluted Unit Amount
2.01(b)
GAAP
2.02(a)(ii)
Governmental Entity
3.06(b)
Gross Enterprise Value
2.01(b)
Gross Redemption Dollar Amount
2.08(a)
Hazardous Substances
3.13
HSR Act
3.06(b)
Indemnification Claim
2.04(b)(ii)
Indemnified Party
10.04(a)
Indemnifying Party
10.04(a)
Independent Accounting Firm
2.03(d)
Index Warrant
2.02(b)
Infringement
3.14(a)
Initial Merger Consideration
2.01(e)
Intellectual Property
3.14(a)
Interim Financial Statements
3.08(a)
Inventions
3.14(a)
Investor
Preamble
Investor Purchase Agreement
Preamble
Investor Recapitalization
Preamble
IP Rights
3.14(a)
Knowledge
11.02(a)
Law
3.06(a)
Legal Proceeding
3.10
Letter of Transmittal
2.02(a)
Liabilities
3.08(b)
Liens
3.17
Losses
10.02(a)
Marks
3.14(a)
Material Contracts
3.12(a)
Measurement Date
2.06(b)
Members
Recitals
Members Expenses
7.05
Members' Representative
10.05(a)
Members' Equity
2.02(a)(i)
Merger
Recitals
Merger Consideration
2.08(k)
Merger Sub
Preamble
MITA
11.02(a)
91
Term
Section
Multi-employer Plan
3.11(c)
Multiple Employer Plan
3.11(c)
Net Income
11.02(a)
Net Redemption Dollar Amount
2.08(a)
New Membership Interests
7.02(b)
Non-Disclosure Agreement
7.03(b)
Non-Solicitation Agreement
7.05(c)
Order
8.01(b)
Parent
Preamble
Parent Audited Financial Statements
5.11(a)
Parent Basic Representations
10.02(b)
Parent Common Stock
Recitals
Parent Disclosure Schedule
Article V
Parent Indemnified Parties
10.02(a)
Parent Interim Financial Statements
5.11(a)
Parent Material Adverse Effect
5.01(a)
Parent Preferred Stock
5.03
Parent Reference Balance Sheet
5.11(a)
Parent SEC Reports
5.05(a)
Parent Shares
2.01(b)
Parent Warrant
2.01(b)
Patton Boggs
1.02
Per Company Interest Cash Consideration
2.01(a)
Person
11.02(a)
Permitted Tax Distribution
11.02(a
Plans
3.11(a)
Preliminary Conversion Schedule
7.16
Private Recapitalization
Preamble
Proceeds
2.03(d)
Proxy Statement
3.32
Redemption Calculations
2.08(a)
Redemption Dispute Notice
2.08(a)
Redemption Liability Amount
2.08(a)
Redemption Liability Shares
2.08(a)
Redemption Notice
2.08(a)
Redemption Option
2.08(a)
Redemption Price